Oxidative Medicine and Cellular Longevity / 2017 / Article / Fig 1

Research Article

Edaravone, a Synthetic Free Radical Scavenger, Enhances Alteplase-Mediated Thrombolysis

Figure 1

Effect of edaravone-alteplase combination therapy in a rat model of thromboembolic clot-induced cerebral ischemia. (a) The experimental groups included the vehicle-injected control group, alteplase group, and edaravone-alteplase combination group ( per group). Rats were killed 24 hours after establishment of cerebral ischemia. (b) Representative figures of 2,3,5-triphenyltetrazolium chloride-stained brain sections of rats. Normal brain tissue stains deep red, and ischemic lesions are white (unstained). (c) Infarct volume in the control, alteplase, and edaravone-alteplase groups. (d) Neurological score in the control, alteplase, and edaravone-alteplase groups. The horizontal lines represent the mean values.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.